Global Oncology Drug Market Status, Trends and COVID-19 Impact Report 2021
In the past few years, the Oncology Drug market experienced a huge change under the
influence of COVID-19, the global market size of Oncology Drug reached (2021 Market size
XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016 with a CAGR of 15 from
2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 200
million, and the global epidemic has been basically under control, therefore, the World Bank
has estimated the global economic growth in 2021 and 2022. The World Bank predicts that
the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in
2022. According to our research on Oncology Drug market and global economic
environment, we forecast that the global market size of Oncology Drug will reach (2026
Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk
by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to
recover and partially adapted to pandemic restrictions. The research and development of
vaccines has made breakthrough progress, and many governments have also issued various
policies to stimulate economic recovery, particularly in the United States, is likely to provide
a strong boost to economic activity but prospects for sustainable growth vary widely
between countries and sectors. Although the global economy is recovering from the great
depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged
period. The pandemic has exacerbated the risks associated with the decade-long wave of
global debt accumulation. It is also likely to steepen the long-expected slowdown in
potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic
environment, we published the Global Oncology Drug Market Status, Trends and COVID-19
Impact Report 2021, which provides a comprehensive analysis of the global Oncology Drug
market , This Report covers the manufacturer data, including: sales volume, price, revenue,
gross margin, business distribution etc., these data help the consumer know about the
competitors better. This report also covers all the regions and countries of the world, which
shows the regional development status, including market size, volume and value, as well as
price data. Besides, the report also covers segment data, including: type wise, industry wise,
channel wise etc. all the data period is from 2015-2021E, this report also provide forecast
data from 2021-2026.
Market Overview
Manufacturer Detail
Roche Ltd
Novartis AG
Bristol-Myers Squibb
Celgene Corporation
Johnson & Johnson
Pfizer Inc.
Astra Zenca Plc
Eli Lilly And Company.
Glaxosmithkline Plc
Merck & Co.
Sanofi
Amgen Inc.
Abbvie
Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Product Type Segmentation
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Application Segmentation
Blood Cancer
Breast Cancer
gastrointestinal Tract Cancer
Prostate Cancer
Lung Cancer/Skin Cancer
Table of Contents
Section 1 Oncology Drug Market Overview
1.1 Oncology Drug Market Scope
1.2 COVID-19 Impact on Oncology Drug Market
1.3 Global Oncology Drug Market Status and Forecast Overview
1.3.1 Global Oncology Drug Market Status 2016-2021
1.3.2 Global Oncology Drug Market Forecast 2021-2026
Section 2 Global Oncology Drug Market Manufacturer Share
2.1 Global Manufacturer Oncology Drug Sales Volume
2.2 Global Manufacturer Oncology Drug Business Revenue
Section 3 Manufacturer Oncology Drug Business Introduction
3.1 Roche Ltd Oncology Drug Business Introduction
3.1.1 Roche Ltd Oncology Drug Sales Volume, Price, Revenue and Gross margin 2016-2021
3.1.2 Roche Ltd Oncology Drug Business Distribution by Region
3.1.3 Roche Ltd Interview Record
3.1.4 Roche Ltd Oncology Drug Business Profile
3.1.5 Roche Ltd Oncology Drug Product Specification
3.2 Novartis AG Oncology Drug Business Introduction
3.2.1 Novartis AG Oncology Drug Sales Volume, Price, Revenue and Gross margin 2016-
2021
3.2.2 Novartis AG Oncology Drug Business Distribution by Region
3.2.3 Interview Record
3.2.4 Novartis AG Oncology Drug Business Overview
3.2.5 Novartis AG Oncology Drug Product Specification
3.3 Manufacturer three Oncology Drug Business Introduction
3.3.1 Manufacturer three Oncology Drug Sales Volume, Price, Revenue and Gross margin
2016-2021
3.3.2 Manufacturer three Oncology Drug Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Oncology Drug Business Overview
3.3.5 Manufacturer three Oncology Drug Product Specification
Section 4 Global Oncology Drug Market Segmentation (By Region)
4.1 North America Country
4.1.1 United States Oncology Drug Market Size and Price Analysis 2016-2021
4.1.2 Canada Oncology Drug Market Size and Price Analysis 2016-2021
4.1.3 Mexico Oncology Drug Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Oncology Drug Market Size and Price Analysis 2016-2021
4.2.2 Argentina Oncology Drug Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Oncology Drug Market Size and Price Analysis 2016-2021
4.3.2 Japan Oncology Drug Market Size and Price Analysis 2016-2021
4.3.3 India Oncology Drug Market Size and Price Analysis 2016-2021
4.3.4 Korea Oncology Drug Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Oncology Drug Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Oncology Drug Market Size and Price Analysis 2016-2021
4.4.2 UK Oncology Drug Market Size and Price Analysis 2016-2021
4.4.3 France Oncology Drug Market Size and Price Analysis 2016-2021
4.4.4 Spain Oncology Drug Market Size and Price Analysis 2016-2021
4.4.5 Italy Oncology Drug Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Oncology Drug Market Size and Price Analysis 2016-2021
4.5.2 Middle East Oncology Drug Market Size and Price Analysis 2016-2021
4.6 Global Oncology Drug Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Oncology Drug Market Segmentation (By Region) Analysis
Section 5 Global Oncology Drug Market Segmentation (by Product Type)
5.1 Product Introduction by Type
5.1.1 Chemotherapy Product Introduction
5.1.2 Targeted Therapy Product Introduction
5.1.3 Immunotherapy Product Introduction
5.1.4 Hormonal Therapy Product Introduction
5.2 Global Oncology Drug Sales Volume by Targeted Therapy016-2021
5.3 Global Oncology Drug Market Size by Targeted Therapy016-2021
5.4 Different Oncology Drug Product Type Price 2016-2021
5.5 Global Oncology Drug Market Segmentation (By Type) Analysis
Section 6 Global Oncology Drug Market Segmentation (by Application)
6.1 Global Oncology Drug Sales Volume by Application 2016-2021
6.2 Global Oncology Drug Market Size by Application 2016-2021
6.2 Oncology Drug Price in Different Application Field 2016-2021
6.3 Global Oncology Drug Market Segmentation (By Application) Analysis
Section 7 Global Oncology Drug Market Segmentation (by Channel)
7.1 Global Oncology Drug Market Segmentation (By Channel) Sales Volume and Share 2016-
2021
7.2 Global Oncology Drug Market Segmentation (By Channel) Analysis
Section 8 Oncology Drug Market Forecast 2021-2026
8.1 Oncology Drug Segmentation Market Forecast 2021-2026 (By Region)
8.2 Oncology Drug Segmentation Market Forecast 2021-2026 (By Type)
8.3 Oncology Drug Segmentation Market Forecast 2021-2026 (By Application)
8.4 Oncology Drug Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Oncology Drug Price Forecast
Section 9 Oncology Drug Application and Client Analysis
9.1 Blood Cancer Customers
9.2 Breast Cancer Customers
9.3 gastrointestinal Tract Cancer Customers
9.4 Prostate Cancer Customers
9.5 Lung Cancer/Skin Cancer Customers
Section 10 Oncology Drug Manufacturing Cost of Analysis
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview
Section 11 Conclusion
Section 12 Methodology and Data Source
Chart and Figure
Figure Oncology Drug Product Picture
Chart Global Oncology Drug Market Size (with or without the impact of COVID-19)
Chart Global Oncology Drug Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Oncology Drug Market Size (Million $) and Growth Rate 2016-2021
Chart Global Oncology Drug Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Oncology Drug Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Oncology Drug Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Oncology Drug Sales Volume Share
Chart 2016-2021 Global Manufacturer Oncology Drug Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Oncology Drug Business Revenue Share
Chart Roche Ltd Oncology Drug Sales Volume, Price, Revenue and Gross margin 2016-2021